Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$269.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 31 most recent Form 4 transactions.
| Mar 4 | VTYX | Ventyx Biosciences, Inc. | DTOISS◆ | 21,825 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | VTYX | Ventyx Biosciences, Inc. | DTOISS◆ | 119,120 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | VTYX | Ventyx Biosciences, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | VTYX | Ventyx Biosciences, Inc. | DTOISS◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | VTYX | Ventyx Biosciences, Inc. | DTOISS◆ | 33,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 24,745 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 74,053 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,073 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 82,482 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 84,051 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 83,400 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 116,833 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 70,279 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 18,964 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,527 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 4,739 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 2,328 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 5,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 47,573 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 10,179 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 659 | $43.02 | $28.4K | -1.1% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 890 | $23.87 | $21.2K | +1.6% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 1,634 | $54.84 | $89.6K | -2.8% | Open the original filing on SEC.gov |
| Jun 11, 2025 | IRON | Disc Medicine, Inc. | AGRANT◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 2,804 | $54.00 | $151.4K | -4.5% | Open the original filing on SEC.gov |
| Jun 5, 2025 | VTYX | Ventyx Biosciences, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |